Centro de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS)

1995

1. A chemoenzymatic synthesis of a-ring key-intermediates for 1α,25-dihydroxyvitamin d 3 and analogues

   Tetrahedron Letters, Vol. 36, Núm. 49, pp. 9023-9026

2. Butyrophenone analogues: Synthesis of 2-methyl-3-ethyl-5-aminoethyl-4,5,6,7-tetrahydroindol-4-ones, and their affinities for d 1 , d 2 and 5-ht 2a receptors

   Bioorganic and Medicinal Chemistry Letters, Vol. 5, Núm. 6, pp. 579-584

3. A mild palladium-catalysed convergent approach to the vitamin D skeleton

   Tetrahedron Letters, Vol. 36, Núm. 30, pp. 5413-5416

4. Absence of growth hormone (GH) secretion after the administration of either GH-releasing hormone (GHRH), GH-releasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary stalk transection

   Journal of Clinical Endocrinology and Metabolism, Vol. 80, Núm. 11, pp. 3180-3184

5. Activation of the SAPK pathway by the human STE20 homologue germinal centre kinase

   Nature, Vol. 377, Núm. 6551, pp. 750-754

6. Activity of leucocyte elastase in women with coronary artery disease documented using angiography

   Journal of Cardiovascular Risk, Vol. 2, Núm. 2, pp. 149-153

7. Allele frequency distribution of four PCR-amplified loci in the Spanish population

   Forensic Science International, Vol. 71, Núm. 2, pp. 153-164

8. Antibodies to the cloned μ-opioid receptor detect various molecular weight forms in areas of mouse brain

   Molecular Pharmacology, Vol. 47, Núm. 4, pp. 738-744

9. Análisis de la variación interna (MVR) del sistema D1S8 utilizando diferentes metodologías

   [Actas de las] VII Jornadasde la Sociedad Española de Medicina Legal y Forense

10. Biopharmaceutical evaluation of microencapsulated ion-exchange resins containing diclofenac

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 41, Núm. 2, pp. 127-131

11. Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: Evidence that GHRP-6 main action is exerted at the hypothalamic level

    Journal of Clinical Endocrinology and Metabolism, Vol. 80, Núm. 3, pp. 942-947

12. CARACTERISTICAS CLINICAS Y PRONOSTICAS E INFLUENCIA DEL TRATAMIENTO FIBRINOLITICO EN EL INFARTO AGUDO DE MIOCARDIO EN PACIENTES DE EDAD AVANZADA

    Revista Espanola de Geriatria y Gerontologia, Vol. 30, Núm. 5, pp. 315-319

13. Casein kinase 2 inactivation by Mg2+, Mn2+ and Co2+ ions

    Molecular and Cellular Biochemistry, Vol. 152, Núm. 1, pp. 1-6

14. Clonidine potentiates the growth hormone response to a growth hormone releasing hormone challenge in hypothalamic growth hormone releasing hormone deficient rats

    Neuroendocrinology, Vol. 61, Núm. 5, pp. 552-558

15. Cortical stimulation induces Fos expression in striatal neurons via NMDA glutamate and dopamine receptors

    Brain Research, Vol. 700, Núm. 1-2, pp. 1-12

16. Detection of c‐erbB‐2/neu and fibroblast growth factor‐3/INT‐2 but not epidermal growth factor receptor gene amplification in endometrial cancer by differential polymerase chain reaction

    Cancer, Vol. 75, Núm. 8, pp. 2139-2146

17. Distribución de polimorfismos de ADN analizados mediante PCR en la población gallega

    [Actas de las] VII Jornadasde la Sociedad Española de Medicina Legal y Forense

18. Distribution of the HLA-DQA1 polymorphism in the population of the Basque Country (Spain).

    Gene geography : a computerized bulletin on human gene frequencies, Vol. 9, Núm. 1, pp. 53-58

19. Doppler echocardiographic comparison of small (19 mm) bileaflet and pericardial heart valve prostheses in aortic position

    Scandinavian Cardiovascular Journal, Vol. 29, Núm. 1, pp. 29-35

20. EFECTOS DE LOS ACEITES RELACIONADOS CON EL SINDROME TOXICO SOBRE LA MOVILIZACION DE CALCIO INTRACELULAR INDUCIDA POR EL FACTOR DE CRECIMIENTO EPIDERMICO Y LA PROLIFERACION CELULAR

    Revista de Toxicologia, Vol. 12, Núm. 2-3, pp. 80-85